Colchicine

Related products

• 

  Langerhans cell histiocytosis , Behcet disease

  Cyclophosphamide

  • 

    other

    Oral live vaccine for type 4 and type 7 adenovirus

    【Product name】Ardovax

    [English common name]Adenovirus types 4 and 7 live

    [Chinese common name]Oral live vaccine for type 4 and type 7 adenovirus

    [English name]

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  Neosar, ENDOXAN

  [English common name] Cyclophosphamide

  [Chinese common name] Cyclophosphamide

  [English name] Cyclophosphamide Sterile

  [Other names in Chinese] P-[N,N-bis(beta-chloroethyl)]
• 

  Langerhans cell histiocytosis , Behcet disease

  Methotrexate

  【Product name】Prosperous, Methotrexat, RHEUMATREX

  [English common name]Methotrexate

  [Chinese common name]Methotrexate

  [English name]

  [Chinese other name]

  [indications]
  Methotrexate injection:
  Methotrexate has broad-spectrum anti-tumor activity and can be used alone or in combination with other chemotherapeutic drugs. The specific indications are as follows:
  1. Anti-tumor treatment alone:Breast cancer, gestational choriocarcinoma,Malignant moleOr a mole.
  2. Anti-tumor therapy combined use:Acute leukemia(especially acuteLymphocytic leukemia), Burkitts lymphoma, advanced lymphosarcoma (stages III and IV, according to Peter staging) and advanced mycosis fungoides.
  3. Intrathecal injection: treatment of meningeal metastases (only isotonic preparations can be used).
  4. High-dose treatment: high-dose methotrexate alone or in combination with other chemotherapeutic drugs for the following tumors: osteosarcoma, acute leukemia, bronchusLung cancerOr head and neck epidermal cancer.
  Methotrexate tablets:
  1. All types of acute leukemia, especially large granular lymphocytic leukemia,Malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides,Multiple myelopathy.
  2. Head and neck cancer, lung cancer, various soft tissue sarcomas, pediatric soft tissue sarcoma, psoriasis.
  3. Breast cancer, ovarian cancer, cervical cancer, malignant mole, chorionic epithelial cancer, testicular cancer, saddle-top germ cell tumor.

  【Dosage】
  Methotrexate injection:
  1. Recommended dose: It is recommended to take sorafenib for 0.4 g (2 × 0.2 g) each time, twice daily, on an empty stomach or with a low-fat, medium-fat diet.
  2. How to take it: Oral, swallow it with a cup of warm water.
  Methotrexate tablets:
  1. Oral, adult 5 ~ 10mg once a day, 1 or 2 times a week, a safe dose of 50 ~ 100mg.
  2. For the maintenance treatment of acute lymphocytic leukemia, once 15 ~ 20mg / m2, once a week.

  [Storage]
  Methotrexate injection: Store at 25 ° C or less in the dark. Each bottle is for one use only, and the excess is discarded.
  Methotrexate tablets: shading, sealed and preserved.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Behcet disease

  Thalidomide

  【Product name】Thalomid

  [English common name]Thalidomide

  [Chinese common name]Thalidomide

  [English name]2-phthalimidoglutarimide

  [Chinese other name]Thalidomide

  [indications]
  Thalidomide capsule: a dermatological treatment. Used to control neoplastic leprosy.
  Thalidomide tablets: used to control neoplastic leprosy.

  【Dosage】
  Thalidomide capsules: 25-50mg (1-2 tablets) once a day, 100-200mg (4-8 tablets) a day or as directed by your doctor.
  Thalidomide tablets: oral. 25-50mg (1-2 tablets), 100-200mg (4-8 tablets) a day, or as directed by your doctor.

  [Storage]
  Thalidomide capsules: shading, sealed storage.
  Thalidomide tablets: shading, sealed and preserved.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Crohn's disease , Behcet disease

  Infliximab

  【Product name】REMICADE, Remicade

  [English common name]Infliximab

  [Chinese common name]Infliximab

  [English name]

  [Chinese other name]

  [indications]
  Rheumatoid Arthritis
  This product is a disease-control anti-rheumatic drug. For patients with moderate to severe active rheumatoid arthritis, this product can be used in combination with methotrexate:
  · Reduce symptoms and signs;
  · Improve physical function and prevent disability in patients.
  Crohn's disease
  For patients with moderate to severe active Crohn's disease who are not well received by traditional treatment, this product can be used for:
  · Reduce symptoms and signs;
  · Achieve and maintain clinical efficacy;
  · Promote mucosal healing;
  · Improve the quality of life;
  · Reduce the amount of corticosteroids or stop using corticosteroids.
  Tracheal Crohn's disease
  For patients with fistile Crohn's disease, this product can be used for:
  Reduce the number of intestinal-cutaneous fistulas and rectal-vaginal fistulas to promote and maintain fistula healing;
  · Reduce symptoms and signs;
  · Improve the quality of life.
  Ankylosing spondylitis
  For patients with active ankylosing spondylitis, this product can be used for:
  · Alleviate symptoms and signs, including increasing the range of activity;
  · Improve physical function;
  · Improve the quality of life.
  psoriasis
  For patients with psoriasis, this product can be used for:
  Adult patients with chronic severe plaque psoriasis who require systemic treatment and are ineffective, contraindicated or tolerant to other systems such as cyclosporine, methotrexate or photochemotherapy. This product is intended for use only in patients who are treated under close supervision by a physician and regularly followed up by a physician.

  【Dosage】
  Usage: intravenous infusion.
  Rheumatoid Arthritis
  The product was administered 3 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. This product should be combined with methotrexate. For patients with poor efficacy, consider adjusting the dose to 10 mg/kg and/or adjusting the medication interval to 4 weeks.
  Moderate and severe active Crohn's disease, fistula Crohn's disease
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. For patients with poor efficacy, consider adjusting the dose to 10 mg/kg.
  Ankylosing spondylitis
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 6 weeks after the second week and the sixth week after the first administration and thereafter.
  User guides
  Sterility should be performed.
  1. Calculate the dosage and determine the number of bottles used in this product: This product contains 100mg of infliximab per bottle, and calculate the total amount of the solution to be prepared.
  2. Dissolve each bottle of medicine with 10 ml of sterile water for injection using a syringe equipped with a 21 gauge (0.8 mm) or smaller needle: remove the flip of the vial, wipe the top of the vial with a medical alcohol swab, and insert the syringe needle into the vial Cover, inject sterile water for injection. If the vacuum in the vial has been destroyed, the bottle cannot be used. Gently rotate the vial to dissolve the powder. Avoid shaking for a long time or with force. Do not oscillate. Foam may appear during the dissolution of the drug. After 5 minutes of storage, the solution should be colorless or light yellow, and the milk is white. Since infliximab is a protein, there may be some translucent particles in the solution. If opaque particles, discoloration or other substances appear in the solution, they cannot be used any more.
  3. Dilute the sterile aqueous solution of this product to 250 ml with 0.9% sodium chloride injection: withdraw the same amount of liquid from the 250 ml 0.9% sodium chloride injection bottle or bag as the sterile injectable aqueous solution of this product. The sterile aqueous solution for injection of this product is completely injected into the infusion bottle or bag and gently mixed.
  4. The infusion time should not be less than 2 hours: the infusion set should be equipped with a built-in, sterile, pyrogen-free, low protein binding filter (pore size ≤ 1.2 μm). Unused infusions should not be stored for further use.
  5. The physical and biochemical compatibility studies of this product in combination with other drugs have not been carried out, and this product should not be infused simultaneously with other drugs.
  Products administered parenterally should be visually inspected for the presence of particulate matter or discoloration prior to administration. If opaque particles, discoloration, or other foreign matter are found, the drug may not be used.
  Plaque psoriasis
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. If the patient does not respond after week 14 (ie, after 4 doses), the product should not be treated.
  Psoriasis patients re-administered
  Patients with psoriasis have limited experience with a single administration after 20 weeks, suggesting a reduction in the effectiveness of the product compared to the initial induction therapy and an increase in mild to moderate infusion response.
  After relapse of the disease, limited experience with repeated induction therapy showed an increase in infusion response (including severe reactions) compared to 8-week maintenance therapy.
  If treatment interruption is maintained, it is not recommended to initiate induction therapy again and should be re-administered according to maintenance therapy.

  [Storage]Store at 2-8 °C in the dark.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.